Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Collman

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Research Initiative, Treatment Action : RITA|July 9, 2003
HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyondRonald G Collman
Expert Opinion on Therapeutic Targets|April 23, 2004
HIV-1 entry inhibitors: closing the front doorBrian Tomkowicz, Ronald G Collman
Current Opinion in Infectious Diseases|April 20, 2004
Co-receptor antagonists as HIV-1 entry inhibitorsFarida Shaheen, Ronald G Collman
The Journal of Infectious Diseases|April 1, 1999
Cofactors for human immunodeficiency virus entry into primary macrophagesR G Collman, Y Yi
Journal of Virology|October 12, 2000
Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispeciesA Singh, R G Collman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 22, 2009
CNS inflammation and macrophage/microglial biology associated with HIV-1 infectionAnjana Yadav, Ronald G Collman
Journal of Leukocyte Biology|July 1, 1997
Chemokine receptors and HIVC C Broder, R G Collman
Journal of Leukocyte Biology|August 23, 2006
HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypesMaureen M Goodenow, Ronald G Collman
Clinics in Laboratory Medicine|September 25, 2002
HIV-1 entry and entry inhibitors as therapeutic agentsLinda D Starr-Spires, Ronald G Collman
Journal of Virology|January 15, 2005
Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytesYanjie Yi, Farida Shaheen, Ronald G Collman
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Research Initiative, Treatment Action : RITA|July 9, 2003
HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyondRonald G Collman
Expert Opinion on Therapeutic Targets|April 23, 2004
HIV-1 entry inhibitors: closing the front doorBrian Tomkowicz, Ronald G Collman
Current Opinion in Infectious Diseases|April 20, 2004
Co-receptor antagonists as HIV-1 entry inhibitorsFarida Shaheen, Ronald G Collman
The Journal of Infectious Diseases|April 1, 1999
Cofactors for human immunodeficiency virus entry into primary macrophagesR G Collman, Y Yi
Journal of Virology|October 12, 2000
Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispeciesA Singh, R G Collman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 22, 2009
CNS inflammation and macrophage/microglial biology associated with HIV-1 infectionAnjana Yadav, Ronald G Collman
Journal of Leukocyte Biology|July 1, 1997
Chemokine receptors and HIVC C Broder, R G Collman
Journal of Leukocyte Biology|August 23, 2006
HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypesMaureen M Goodenow, Ronald G Collman
Clinics in Laboratory Medicine|September 25, 2002
HIV-1 entry and entry inhibitors as therapeutic agentsLinda D Starr-Spires, Ronald G Collman
Journal of Virology|January 15, 2005
Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytesYanjie Yi, Farida Shaheen, Ronald G Collman
Pageof 23